A drug used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could have further uses, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute including Professor Joanna Porter (UCL Medicine).
Read: Pharma Times, More: MSN, Medical Xpress, UCL News
Close
